The «ICD-11 classification in ANASALVA » is a proposal made by the World Health Organization (WHO) and officially launched in January 2022, represents a significant evolution in the coding of medical and health conditions. This new classification, designed to be more user-friendly and provide better guidance, provides a robust and up-to-date framework for coding various conditions to the desired level of detail.
One of its strengths lies in the inclusion of primary care, cancer coding, as well as the integration of traditional medicine, which allows for a more complete and accurate representation of health and its challenges in today's society. The ICD-11 Classification in ANASALVA is kept up to date with the latest regulations and coding standards established by the WHO.
ICD-11 provides a broader framework that more accurately captures the complexity and diversity of health conditions, reflecting an up-to-date understanding of medicine and public health. This is invaluable to healthcare professionals, enabling them to accurately code and document health conditions, facilitating research, informed clinical decision making and healthcare planning.
The integration of the ICD-11 Classification into ANASALVA represents a significant advance for the accurate coding and classification of medical conditions, contributing to a more complete and up-to-date representation of health and its challenges in the field of modern medicine.
EN 
ES